Evidence-based diagnosis and thrombolytic treatment of cardiac arrest or periarrest due to suspected pulmonary embolism

American Journal of Emergency Medicine

Volumn 32, Issue 7, 2014, Pages 789-796

  Logan, Jill K ^a   Pantle, Hardin ^b   Huiras, Paul ^c   Bessman, Edward ^b   Bright, Leah ^d  

^a UNIVERSITY OF MARYLAND   (United States)

^b JOHNS HOPKINS BAYVIEW MEDICAL CENTER   (United States)

^c BOSTON MEDICAL CENTER   (United States)

^d JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOLYTIC AGENT; HEPARIN; STREPTOKINASE; TENECTEPLASE; UROKINASE;

ACUTE HEART INFARCTION; BLEEDING; BRAIN HEMORRHAGE; CARDIAC PATIENT; CARDIOVERSION; CLINICAL DECISION MAKING; CLINICAL FEATURE; COMPRESSION; EARLY DIAGNOSIS; ELECTRIC ACTIVITY; EVIDENCE BASED PRACTICE; FIBRINOLYTIC THERAPY; HEART ARREST; HEART RHYTHM; HEART VENTRICLE FUNCTION; HEART VENTRICLE PRESSURE; HOSPITAL BILLING; HOSPITAL DISCHARGE; HUMAN; LUNG ARTERY PRESSURE; LUNG EMBOLISM; OUT OF HOSPITAL CARDIAC ARREST; PATHOPHYSIOLOGY; PATIENT IDENTIFICATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESUSCITATION; RETURN OF SPONTANEOUS CIRCULATION; REVIEW; RISK BENEFIT ANALYSIS; SHOCK; TIME TO TREATMENT;

FIBRINOLYTIC AGENTS; HEART ARREST; HUMANS; PULMONARY EMBOLISM; RECOMBINANT PROTEINS; STREPTOKINASE; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE-TYPE PLASMINOGEN ACTIVATOR;

EID: 84903119439     PISSN: 07356757     EISSN: 15328171     Source Type: Journal    
DOI: 10.1016/j.ajem.2014.04.032     Document Type: Review

References (54)

1. E.P. Hess, R.L. Campbell, and R.D. White Epidemiology, trends, and outcome of out-of-hospital cardiac arrest of non-cardiac origin Resuscitation 72 2 2007 200 206
2. M. Kuisma, and A. Alaspaa Out-of-hospital cardiac arrests of non-cardiac origin Eur Heart J 18 1997 1122 1128
3. C. Deasy, J.E. Bray, K. Smith, L.R. Harriss, S.A. Bernard, and P. Cameron Out-of-hospital cardiac arrest in young adults in Melbourne, Australia - adding coronial data to cardiac arrest registry Resuscitation 82 2011 1302 1306
4. R.W. Neumar, M.S. Otto CWL, and S.L. Kronik et al. Part 8: Adult advanced cardiovascular life support: 2010 American Heart Association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care Circulation 122 2010 S729 S767
5. S.Z. Goldhaber, L. Visani, and M. De Rosa Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER) Lancet 353 1999 1386 1389
6. W. Kasper, S. Konstantinides, and A. Geibel et al. Management strategies and determinants of outcome in acute major pulmonary embolism: results of a multicenter registry J Am Coll Cardiol 30 1997 1165 1171
7. D.M. Courtney, H.C. Sasser, C.L. Pincus, and J.A. Kline Pulseless electrical activity with witnessed arrest as a predictor of sudden death from massive pulmonary embolism in outpatients Resuscitation 49 2001 265 272
8. S. Wan, D.J. Quinlan, G. Agnelli, and J.W. Eikelboom Thombolysis compared with heparin for the initial treatment of pulmonary embolism: a meta-analysis of the randomized controlled trials Circulation 110 2004 744 749
9. L.J. Morrison, C.D. Deakin, and P.T. Morley et al. Part 8: advanced life support: 2010 international consensus on cardiopulmonary resuscitation and emergency cardiovascular care science with treatment recommendations Circulation 122 2010 S345 S421
10. C.D. Deakin, J.P. Nolan, and J. Soar et al. European resuscitation council guidelines for resuscitation 2010 section 4. Adult advanced life support Resuscitation 81 2010 1305 1352
11. E.E. Cliffton, and M. Grunnett Investigations of intravenous plasmin (fibrinolysin) in humans Circulation 14 5 1956 919
12. E.E. Cliffton The use of plasmin in humans Ann N Y Acad Sci 68 1957 209 229
13. C.T. Dotter, J. Rosch, and A.J. Seaman Selective clot lysis with low-dose streptokinase Radiology 111 1974 31 37
14. A. van Breda, J.C. Robinson, and L. Feldman et al. Local thrombolysis in the treatment of arterial graft occlusions J Vasc Surg 1 1984 103 112
15. R.A. Graor, B. Risius, and K.M. Denny et al. Local thrombolysis in the treatment of thrombosed arteries, bypass grafts, and arteriovenous fistulas J Vasc Surg 2 1985 406 414
16. R.J. Boucek, and W.P. Murphy Segmental perfusion of the coronary arteries with fibrinolysin in man following a myocardial infarction Am J Cardiol 6 1960 525 533
17. A.E. El-Gengaihy, S.I. Abdelhadi, J.F. Kirmani, and A.I. Qureshi Thrombolytics (chapter 34) comprehensive medicinal chemistry II: Volume 6: Therapeutic areas I: Central nervous system, pain, metabolic syndrome, urology, gastrointestinal and cardiovascular 2007 Elsevier Science
18. Micromedex Healthcare Series Thomson Reuters (Healthcare) Web site http://www.thomsonhc.com [Accessed April 12, 2013]
19. D. Collen Molecular mechanisms of fibrinolysis and their application to fibrin-specific thrombolytic therapy J Cell Biochem 33 1987 77 86
20. K. Ouriel A history of thrombolytic therapy J Endovasc Ther 11 2004 128S 133S
21. E.M. Ohman, R.A. Harrington, C.P. Cannon, G. Agnelli, J.A. Cairns, and J.W. Kennedy Intravenous thrombolysis in acute myocardial infarction Chest 199 2001 253S-277S
22. M.B. Wooster, and A.B. Luzier Reteplase: a new thrombolytic for the treatment of acute myocardial infarction Ann Pharmacother 33 3 1999 318 324
23. C. Landy, D. Plancade, N. Gagnon, E. Schaeffer, J. Nadaud, and J.C. Favier Letter to the editor. Complication of intraosseous administration of systemic fibrinolysis for a massive pulmonary embolism with cardiac arrest Resuscitation 86 6 2012 e149 e150
24. M. Pokorna, E. Necas, R. Skripsky, J. Kratochvil, M. Andrlik, and O. Franek How accurately can the aetiology of cardiac arrest be established in an out-of-hospital setting? analysis by "concordance in diagnosis crosscheck tables" Resuscitation 82 2011 391 397
25. E.E. Unluer, G.O. Senturk, A. Karagoz, Y. Uyal, and S. Bayata Red flag in bedside echocardiography for acute pulmonary embolism: remembering McConnell's sign Am J Emerg Med 31 2013 719 721
26. N.S. Gibson, M. Sohne, and M.J.H.A. Kruip et al. Further validation and simplification of the wells clinical decision rule in pulmonary embolism Thromb Haemost 99 2008 229 234
27. A. Penaloza, P.M. Roy, and J. Kline Risk stratification and treatment strategy of pulmonary embolism Curr Opin Crit Care 18 4 2012 318 325
28. O. Sanchez, L. Trinquart, and V. Caille et al. Prognostic factors for pulmonary embolism. the PREP study, a prospective multicenter cohort study Am J Respir Crit Care Med 181 2010 168 173
29. K.A. Comess, F.A. DeRook, M.L. Russell, T.A. Tognazzi-Evans, and K.W. Beach The incidence of pulmonary embolism in unexplained sudden cardiac arrest with pulseless electrical activity Am J Med 109 2000 351 356
30. D.M. Courtney, and J.A. Kline Prospective use of a clinical decision rule to identify pulmonary embolism as likely cause of outpatient cardiac arrest Resuscitation 65 2005 57 64
31. D.M. Courtney, J.A. Kline, and C. Kabrhel et al. Clinical features from the history and physical examination that predict the presence or absence of pulmonary embolism in symptomatic emergency department patients: results of a prospective, multicenter study Ann Emerg Med 55 2010 307 315
32. S.Z. Goldhaber Echocardiography in the management of pulmonary embolism Ann Intern Med 136 2002 691 700
33. P.D. Stein, and F. Matta Thrombolytic therapy in unstable patients with acute pulmonary embolism: saves lives but underused Am J Med 125 2012 465 470
34. F. Er, A.M. Nia, N. Gassanov, E. Caglayan, E. Erdmann, and U.C. Hoppe Impact of rescue-thrombolysis during cardiopulmonary resuscitation in patients with pulmonary embolism PLoS One 4 12 2009 e8323 e8328
35. M. Levine, J. Hirsh, and J. Weitz et al. A randomized trial of a single bolus dosage regimen of recombinant tissue plasminogen activator in patients with acute pulmonary embolism Chest 98 1990 1473 1479
36. B. Ly, H. Arnesen, H. Eie, and R. Hol A controlled clinical trial of streptokinase and heparin in the treatment of major pulmonary embolism Acta Med Scand 203 1978 465 470
37. S. Dalla-Volta, A. Palla, and A. Santolicandro et al. PAIMS 2: alteplase combined with heparin versus heparin in the treatment of acute pulmonary embolism. Plasminogen Activator Italian Multicenter Study 2 J Am Coll Cardiol 20 3 1992 520 526
38. S.Z. Goldhaber, W.D. Haire, and M.L. Feldstein et al. Alteplase versus heparin in acute pulmonary embolism: randomized trial assessing right-ventricular function and pulmonary perfusion Lancet 341 1993 507 511
39. PIOPED investigators Tissue plasminogen activator for the treatment of acute pulmonary embolism Chest 97 1990 528 533
40. S. Konstantinides, A. Geibel, G. Heusel, F. Heinrich, and K. Wolfgang Heparin plus alteplase compared with heparin alone in patients with submassive pulmonary embolism N Engl J Med 347 2002 1143 1150
41. C. Jerjes-Sanchez, A. Ramirez-Rivera, and Garcia M. de Lourdes et al. Streptokinase and heparin versus heparin alone in massive pulmonary embolism: a randomized controlled trial J Thromb Thrombolysis 2 1995 227 229
42. P. Le Conte, L. Huchet, and D. Trewick et al. Efficacy of alteplase thrombolysis for ED treatment of pulmonary embolism with shock Am J Emerg Med 21 2003 438 440
43. B.W. Böttiger, C. Bode, and S. Kern et al. Efficacy and safety of thrombolytic therapy after initially unsuccessful cardiopulmonary resuscitation: a prospective clinical trial Lancet 357 2001 1583 1585
44. R.B. Abu-Laban, J.M. Christenson, and G.D. Innes et al. Tissue plasminogen activator in cardiac arrest with pulseless electrical activity N Engl J Med 346 2002 1522 1528
45. D.M. Fatovich, G.J. Dobb, and R.A. Clugston A pilot randomized trial of thrombolysis in cardiac arrest (the TICA trial) Resuscitation 61 2004 309 313
46. W.P. Bozeman, D.M. Kleiner, and K.L. Ferguson Empiric tenecteplase is associated with increased return of spontaneous circulation and short term survival in cardiac arrest patients unresponsive to standard intervention Resuscitation 69 2006 399 406
47. B.W. Böttiger, H.R. Arntz, and D.A. Chamberlain et al. Thombolysis during resuscitation for out-of-hospital cardiac arrest N Engl J Med 359 2008 2651 2662
48. I. Kurkciyan, G. Meron, and F. Sterz et al. Pulmonary embolism as cause of cardiac arrest Arch Intern Med 160 2000 1529 1535
49. I. Kurkciyan, G. Meron, and F. Sterz et al. Major bleeding complications after cardiopulmonary resuscitation: impact of thrombolytic treatment J Intern Med 253 2003 128 135
50. W. Lederer, C. Lichtenberger, C. Pechlaner, G. Kroesen, and M. Baubin Recombinant tissue plasminogen activator during cardiopulmonary resuscitation in 108 patients with out-of-hospital cardiac arrest Resuscitation 50 2001 71 76
51. K. Janata, M. Holzer, and I. Kurkciyan et al. Major bleeding complications in cardiopulmonary resuscitation: the place of thrombolytic therapy in cardiac arrest due to massive pulmonary embolism Resuscitation 57 2003 49 55
52. T.L. Vanden Hoek, L.J. Morrison, and M. Shuster et al. Part 12: cardiac arrest in special populations: 2010 American Heart Association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care Circulation 122 2010 S829 S861
53. B.T.A. Fengler, and W.J. Brady Fibrinolytic therapy in pulmonary embolism: an evidence-based treatment algorithm Am J Emerg Med. 27 2009 84 95
54. M.H. A. Ebell, J. Siwek, and B.D. Weiss et al. Strength of recommendation taxonomy (SORT): a patient-centered approach to grading evidence in the medicalliterature J Am Board Fam Pract. 17 2004 59 67